What stage does Xenia Venture Capital invest at?

Xenia Venture Capital invests at the Seed, Series A stages.

Where is Xenia Venture Capital located?

Xenia Venture Capital is headquartered in Tel Aviv, IL.

Xenia Venture Capital

Venture capital

Tel Aviv · Seed–Series A · 6 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Xenia Venture Capital invests mainly in life science companies based in Israel. Beyond financing, the firm supports portfolio companies with mentoring, business and strategic guidance, fundraising assistance, and exit planning. It holds a 50% stake in VLX, a technological incubator running under the Israel Innovation Authority's incubator program. Xenia actively looks for promising ideas with the potential to grow into multi-million dollar companies.

Invests inBiotech Data & Infrastructure Enterprise Software Hardware Healthtech Medical Devices SaaSIsraelTel AvivUnited Arab Emirates

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series A

Tel Aviv, IL

Instruments

Equity

Founded

2003

Tracked investments

Team · 6 people

from the firm's website & public directories

Anat Tsour Segal· Board Member

An investor, business executive and entrepreneur focused on developing Israel's high technology ecosystem, with emphasis on planet, medical and cyber infrastructure technologies.

Erez I. Meltzer· Board Member

Erez Meltzer has more than 35 years of experience as a chairman and CEO across global companies. He is currently CEO of Nanox Vision and holds executive chairman and vice chairman roles at Israeli companies in the agro-tech and biomed sectors. His prior positions include CEO of Gadot Chemicals & Shipping Group, CEO of Africa-Israel Ltd., President and CEO of Netafim, and President and CEO of CreoScitex; he also formerly chaired the board of Hadassah University Medical Center.

Merav Kaye· Board Member

Merav Kaye works in project management and business development, and currently serves as an investment manager at Consensus Business Group, a UK investment group. She previously worked at a large telecoms company and managed organisational projects at 012 Smile Ltd. She serves as a director at several companies and has experience guiding companies from early startup stage through IPO.

Rotem Yehuda Kakon· Board Member

Rotem Yehuda Kakon has over 12 years of experience across venture capital, business development, entrepreneurship, and the public sector, and has served on the boards of multiple high-tech and industrial companies. He is a strategic investor and portfolio manager advisor at CBG and a limited partner in more than 15 venture capital funds representing $100M under management. He previously advised the Israeli Ministry of Economy and Industry and the Ministry of Environmental Protection, worked in business development at ANS Tech, and holds a B.A. in Economics and Management and an MBA in Business Strategy from Bar-Ilan University.

Eli Sorzon· CFO

Eli Sorzon is the CFO at Xenia Venture Capital, which he joined in February 2007, and has over a decade of experience in accounting and finance, largely with publicly traded high-tech companies. Before Xenia, he held manager roles at the accounting firm Deloitte Brightman Almagor and at the Tel Aviv firm Goldstein Sabo Tevet. He is a CPA and holds a bachelor's degree in Business Administration from the College of Management Academic Studies Division.

e•••@xenia.co.ilreveal

Ori· Vice President· Tel Aviv-Yafo, Tel Aviv District, Israelin

Ori is CEO of DisperseBio and Chairman of NetwoRx Bio, where he applies artificial intelligence and computational biology to precision immuno-oncology. He previously founded and led VLX Ventures, a venture builder that established over 12 biotech and computational biology companies, and held senior leadership positions at M-Systems (acquired by SanDisk for $1.6 billion), Hutchison, and Orange, including roles in global partnerships and early 3G technology deployment. His background spans two decades in AI, life sciences, and technology.

Investments · 4 tracked

founders shown can be your intro path

PolyPidNASDAQ: PYPD

Bio Protectbioprotect.comin 𝕏

Keepmed

Medi-tate

Exits · 1

IPOs and acquisitions across the tracked portfolio

PolyPidNASDAQ: PYPD

Frequently asked questions

What stage does Xenia Venture Capital invest at?: Xenia Venture Capital invests at the Seed, Series A stages.
What sectors does Xenia Venture Capital focus on?: Xenia Venture Capital focuses on Biotech, Data & Infrastructure, Enterprise Software, Hardware, Healthtech, Medical Devices, SaaS.
Where is Xenia Venture Capital located?: Xenia Venture Capital is headquartered in Tel Aviv, IL.

Similar investors

ACT Venture Capital

ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.

$1.1M – $16.2M

DCVC (Data Collective)

DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.

$5M – $25M

EDB Investments

EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.

$12M – $400M

Excell Partners

Excell Partners manages a state-supported fund in partnership with the University of Rochester and New York State, offering pre-seed and seed stage capital to early-stage technology companies in Upstate New York.

$100K – $500K

GV (Google Ventures)

GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.

$250K – $50M